Interventional Cardiologist, Assistant Professor of Medicine
Duke Clinical Research Institute
Institut de Cardiologie de Montréal, Canada
Bayer (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)CSI (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)JAMP Pharma (Consultant/Advisory Board)KYE (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Novartis (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Pharmascience (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Servier (Consultant/Advisory Board)
I am an interventional cardiologist and am currently enrolled in a 2-year clinical research fellowship at the Duke Clinical Research Institute, where my main research interests revolve around coronary intervention strategies and devices. Following my training in June 2020, I am appointed as a clinician-scientist in an academic center. I am interesting in developing skills and expertise in interventional device development during my training. I am also interested in development of innovative and technology-enabled clinical trials methods to streamline the generation of knowledge. My main focus of research interests are antithrombotic management of coronary artery disease, percutaneous coronary intervention, and cardiogenic shock.